Stemtech Corp, a Hong Kong-based company listed on the OTC Bulletin Board, is currently experiencing financial challenges with a negative price-to-earnings ratio and fluctuating stock price.

Stemtech Corporation makes strategic moves in 2025, launching a video series on ‘Well-Aging’ and expanding into the pet supplement market through a manufacturing agreement with Pure Solutions Inc.